
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
10/15/2025 | Q3 | $391.3M | -- | -- | $1.43 | -- |
07/15/2025 | Q2 | $376.2M | $375.5M | $1.32 | $1.36 | -$0.04 |
04/15/2025 | Q1 | $368M | $362.8M | $1.38 | $1.29 | $0.09 |
01/21/2025 | Q4 | $365.1M | $363.7M | $1.40 | $1.28 | $0.12 |
10/15/2024 | Q3 | $367.2M | $364.7M | $1.33 | $1.30 | $0.03 |
07/16/2024 | Q2 | $359.1M | $358.6M | $1.31 | $1.20 | $0.11 |
04/16/2024 | Q1 | $356.4M | $351.2M | $1.24 | $1.18 | $0.06 |
01/16/2024 | Q4 | $344M | $291.3M | $0.58 | $1.12 | -$0.54 |
10/17/2023 | Q3 | $358M | $353.9M | $1.12 | $1.03 | $0.09 |
07/18/2023 | Q2 | $364.6M | $356.5M | $1.35 | $1.34 | $0.01 |
04/18/2023 | Q1 | -- | $364.9M | $1.45 | -- | -- |
01/17/2023 | Q4 | -- | $369.5M | $1.65 | -- | -- |
10/18/2022 | Q3 | -- | $365.6M | $1.55 | -- | -- |
07/19/2022 | Q2 | -- | $331.4M | $1.38 | -- | -- |
04/19/2022 | Q1 | -- | $311.9M | $1.40 | -- | -- |
01/18/2022 | Q4 | -- | $317.5M | $1.55 | -- | -- |
10/19/2021 | Q3 | -- | $328.1M | $1.46 | -- | -- |
07/20/2021 | Q2 | -- | $328.9M | $1.00 | -- | -- |
04/20/2021 | Q1 | -- | $321.7M | $1.21 | -- | -- |
01/20/2021 | Q4 | -- | $320.6M | $1.17 | -- | -- |
10/20/2020 | Q3 | -- | $318.9M | $0.90 | -- | -- |
07/21/2020 | Q2 | -- | $311.8M | -$1.36 | -- | -- |
04/28/2020 | Q1 | -- | $315.6M | -$1.28 | -- | -- |
01/15/2020 | Q4 | -- | $316.1M | $1.03 | -- | -- |
10/15/2019 | Q3 | -- | $306.2M | $0.77 | -- | -- |
07/16/2019 | Q2 | -- | $299.1M | $1.01 | -- | -- |
04/16/2019 | Q1 | -- | $289.8M | $0.91 | -- | -- |
01/16/2019 | Q4 | -- | $267.3M | $1.10 | -- | -- |
10/16/2018 | Q3 | -- | $289.7M | $0.96 | -- | -- |
07/17/2018 | Q2 | -- | $280.4M | $0.82 | -- | -- |
04/17/2018 | Q1 | -- | $271.9M | $0.83 | -- | -- |
01/17/2018 | Q4 | -- | $267.8M | $0.64 | -- | -- |
10/17/2017 | Q3 | -- | $270M | $0.68 | -- | -- |
07/18/2017 | Q2 | -- | $268.5M | $0.60 | -- | -- |
04/18/2017 | Q1 | -- | $246.3M | $0.57 | -- | -- |
01/17/2017 | Q4 | -- | $227.1M | $0.64 | -- | -- |
10/19/2016 | Q3 | -- | $228.1M | $0.59 | -- | -- |
07/20/2016 | Q2 | -- | $230.2M | $0.59 | -- | -- |
04/20/2016 | Q1 | -- | $222.6M | $0.05 | -- | -- |
01/21/2016 | Q4 | -- | $219.8M | $0.19 | -- | -- |
10/23/2015 | Q3 | -- | $218.6M | $0.52 | -- | -- |
Hancock Whitney reported $375.5M worth of top line sales in its most recent quarter.
Hancock Whitney announced earnings per share of $1.32 which represents a miss of analyst forecast a $1.36 per share.
Hancock Whitney reported -- that represents -- per share over the last quarter.
Hancock Whitney's earnings are forecast to grow from $5.28 per share to $5.20 per share next year representing an increase of 6.41%.
Hancock Whitney's next earnings date is October 15, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.